from the people in the know, page-4

99% of doctors stay away from anything thats new and is not endorsed. Its called public indemnity insurance and loss of medical license. KSX would not be relying on this market for its sales.

Only matters if its accurate, got the right approvals, is safe, endorsed by the right professions (give 'em a few oppies and im sure they'll like it) and if a distributor can add value (make money) by selling it PUBLICLY (in what ever country) to those that actually have or need to monitor asthma.

Personally I see a market for it as does the bloke who thought so too, to the tune of 7.6millions shares and 7.6million short dated options...oh wait that's the director!

Can't see any major action though until post-option expiry. Keep the stock at 12-14c and bid the options at .01c waiting for those who can't afford to exercise to sell out. Then stock rocket the sp thankyou very much.

Just my opinion only.